Posted On: 03/06/2016 2:00:59 PM
Post# of 30066
In the presentation a few weeks ago, GC used inVivo as a comp to ESS. Not the whole company, but just ESS.
inVivo has almost doubled in the last two weeks and now has a market cap for $200m.
A $200m cap for AMBS would be a 50 bagger at these levels. Someone investing $20K now could be looking at $1M.
http://www.invivotherapeutics.com/research-cl.../pipeline/
inVivo has almost doubled in the last two weeks and now has a market cap for $200m.
A $200m cap for AMBS would be a 50 bagger at these levels. Someone investing $20K now could be looking at $1M.
http://www.invivotherapeutics.com/research-cl.../pipeline/
(3)
(0)
